Healthcap Vii, L.p. - Net Worth and Insider Trading
Healthcap Vii, L.p. Net Worth
The estimated net worth of Healthcap Vii, L.p. is at least $82 Million dollars as of 2024-11-13. Healthcap Vii, L.p. is the 10% Owner of Fusion Pharmaceuticals Inc and owns about 3,807,247 shares of Fusion Pharmaceuticals Inc (FUSN) stock worth over $82 Million. Healthcap Vii, L.p. is also the 10% Owner of Aprea Therapeutics Inc and owns about 118,305 shares of Aprea Therapeutics Inc (APRE) stock worth over $405,786. Details can be seen in Healthcap Vii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Healthcap Vii, L.p. has not made any transactions after 2020-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Healthcap Vii, L.p.
Healthcap Vii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Healthcap Vii, L.p. owns 2 companies in total, including Aprea Therapeutics Inc (APRE) , and Fusion Pharmaceuticals Inc (FUSN) .
Click here to see the complete history of Healthcap Vii, L.p.’s form 4 insider trades.
Insider Ownership Summary of Healthcap Vii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2019-10-07 | 10 percent owner |
| FUSN | Fusion Pharmaceuticals Inc | 2020-06-30 | 10 percent owner |
Healthcap Vii, L.p. Latest Holdings Summary
Healthcap Vii, L.p. currently owns a total of 2 stocks. Among these stocks, Healthcap Vii, L.p. owns 3,807,247 shares of Fusion Pharmaceuticals Inc (FUSN) as of June 30, 2020, with a value of $82 Million and a weighting of 99.51%. Healthcap Vii, L.p. also owns 118,305 shares of Aprea Therapeutics Inc (APRE) as of October 7, 2019, with a value of $405,786 and a weighting of 0.49%.
Latest Holdings of Healthcap Vii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FUSN | Fusion Pharmaceuticals Inc | 2020-06-30 | 3,807,247 | 21.55 | 82,046,173 |
| APRE | Aprea Therapeutics Inc | 2019-10-07 | 118,305 | 3.43 | 405,786 |
Holding Weightings of Healthcap Vii, L.p.
Healthcap Vii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Healthcap Vii, L.p. has made a total of 1 transactions in Fusion Pharmaceuticals Inc (FUSN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fusion Pharmaceuticals Inc is the acquisition of 240,000 shares on June 30, 2020, which cost Healthcap Vii, L.p. around $4 Million.
According to the SEC Form 4 filings, Healthcap Vii, L.p. has made a total of 0 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 13,333 shares on October 7, 2019, which cost Healthcap Vii, L.p. around $4 Million.
Insider Trading History of Healthcap Vii, L.p.
- 1
Healthcap Vii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Healthcap Vii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Healthcap Vii, L.p. is 41.96%. GuruFocus also compares Healthcap Vii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Healthcap Vii, L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Healthcap Vii, L.p.'s insider trading performs compared to the benchmark.
Performance of Healthcap Vii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.57 | | | | | |
| Relative Return to S&P 500(%) | -6.42 | | | | | |
Healthcap Vii, L.p. Ownership Network
Ownership Network List of Healthcap Vii, L.p.
Ownership Network Relation of Healthcap Vii, L.p.
Healthcap Vii, L.p. Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Healthcap Vii, L.p. is the 10 percent owner of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Healthcap Vii, L.p. made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 26,957 shares made by Bernd R. Seizinger , and a net purchase of 23,728 shares made by Marc Duey .
In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 69,417 shares were bought by its insiders, resulting in a net purchase of 62,955 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Healthcap Vii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Healthcap Vii, L.p.. You might contact Healthcap Vii, L.p. via mailing address: 18 Avenue D'ouchy, Ch 1006 Lausanne V8 1000-1018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
